This suspicion is based on: (a) our finding that these Epilepsy patients have 3 types of GluR antibodies in their sera, and (b) these specific types of GluR antibodies, have already been shown to induce multiple pathological effects In vitro and In vivo [reviewed in Levite and Goldberg (2021) and summarized also in the next paragraphs]. This evidence concerns the gene GSR and epilepsy.